Post a Comment Print Share on Facebook

Setback for Bayer in the glyphosate-armed

A U.S. Jury finds that the controversial active ingredient glyphosate, was a major factor for the cancer disease of a claimant. For Bayer, this is highly explos

- 15 reads.

Setback for Bayer in the glyphosate-armed

A U.S. Jury finds that the controversial active ingredient glyphosate, was a major factor for the cancer disease of a claimant. For Bayer, this is highly explosive.

The agricultural chemical and pharmaceutical group Bayer has lost in the USA, an important part of the process to the alleged cancer risks of products of the subsidiaries of Monsanto. A Jury of the competent Federal district court in San Francisco ruled on Tuesday unanimously that the weed killer Roundup with the controversial active ingredient glyphosate glands is a key factor for the lymphatic cancer has been the disease of the plaintiff, Edwin Hardeman. Thus, the process is now in a second Phase, to clarify, whether or not Monsanto deceived about the risks and the possible damages could be.

To Bayer, this case is highly controversial, because it is a Bellwether Case. Thus, a kind of pattern case in US law in a mass procedure. Several of these representative cases are reported. They should help the parties to the dispute, to the extent of damage and the amount of possible payments of compensation better estimate. A total of several Hundred actions brought by farmers, gardeners and consumers in the relevant U.S. judge Vince Chhabria bundled.

Avatar
Your Name
Post a Comment
Characters Left:
Your comment has been forwarded to the administrator for approval.×
Warning! Will constitute a criminal offense, illegal, threatening, offensive, insulting and swearing, derogatory, defamatory, vulgar, pornographic, indecent, personality rights, damaging or similar nature in the nature of all kinds of financial content, legal, criminal and administrative responsibility for the content of the sender member / members are belong.